No Data
No Data
Express News | AngioDynamics Inc: New Data Finds Alphavac F18(85) System Provides Significant Improvement in Right Ventricular Function and Reduction in Clot Burden
Express News | AngioDynamics Inc: New Data Finds Alphavac F18(85) System Safe in Patients With Acute Intermediate-Risk Pulmonary Embolism
Express News | AngioDynamics’ Apex-Av Trial Results Assessing Alphavac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at Scai 2024 Scientific Sessions
Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks
CEO, President & Director of AngioDynamics Picks Up 2.6% More Stock
Whilst it may not be a huge deal, we thought it was good to see that the AngioDynamics, Inc. (NASDAQ:ANGO) CEO, President & Director, James Clemmer, recently bought US$67k worth of stock, for US$6.70 per share.
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Catapults 25% Though Its Price And Business Still Lag The Industry
AngioDynamics, Inc. (NASDAQ:ANGO) shares have had a really impressive month, gaining 25% after a shaky period beforehand. Unfortunately, the gains of the last month did little to right the losses o